Skip to Content

JSP 513 (Levothyroxine 25 mcg (0.025 mg))

Pill imprint JSP 513 has been identified as Levothyroxine sodium 25 mcg (0.025 mg).

Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 25 mcg (0.025 mg) is not a controlled substance under the Controlled Substance Act (CSA).

Levothyroxine sodium 25 mcg (0.025 mg) JSP 513
Levothyroxine sodium 25 mcg (0.025 mg) JSP 513 Front
Levothyroxine sodium 25 mcg (0.025 mg) JSP 513 Back
Levothyroxine sodium 25 mcg (0.025 mg) JSP 513
Levothyroxine sodium
JSP 513
25 mcg (0.025 mg)
7.00 mm
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
Not a controlled drug
Lannett Company, Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
magnesium stearate
microcrystalline cellulose
corn starch
sodium starch glycolate type A potato
FD&C Yellow No. 6
aluminum oxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00527-1370 Lannett Company, Inc.
62584-0146 Amerisource Health Services
00527-1370 Lannett Company, Inc.
68115-0198 Dispensexpress Inc (repackager)
66336-0254 Dispensing Solutions Inc. (repackager)
23490-6378 Palmetto State Pharmaceuticals Inc (repackager)
21695-0748 Rebel Distributors Corp (repackager)
57866-5503 Direct Dispensing Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.